Access cutting-edge myasthenia gravis treatment through this clinical trial at a research site in Sacramento. Study-provided care at no cost to qualified participants.
Access myasthenia gravis specialists in Sacramento at no cost
This study follows strict safety protocols and ethical guidelines
All study-related myasthenia gravis treatment provided free
The study is a randomized, double-blind, placebo-controlled, multicenter, Phase III study, to evaluate efficacy, safety and tolerability of iptacopan in patients with AChR+ gMG who are on stable SOC treatment. Participants who meet the eligibility criteria will be randomized in a ratio of 1:1, to receive either iptacopan or matching placebo, for 6 months (180 days) while continuing on a stable SOC treatment. The randomization will be stratified based on region.
Sponsor: Novartis Pharmaceuticals
Check if you qualify for this myasthenia gravis clinical trial in Sacramento, CA
If you're searching for myasthenia gravis treatment options in Sacramento, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Sacramento research site is actively enrolling participants for this clinical trial. You'll receive care from experienced myasthenia gravis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.